Thieblemont C, Colrat F, Sellami R, Sivignon M, et al. Cost-Effectiveness Analysis of Second-Line Lisocabtagene Maraleucel in the Treatment of Refractory or Relapsed Large B-Cell Lymphoma. Eur J Haematol 2026 Feb 6. doi: 10.1111/ejh.70131.
PMID: 41651792